You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dopamine D1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cocaine Use Disorder Trial in New Haven (Calcitriol, Placebo)

Suspended
  • Cocaine Use Disorder
  • New Haven, Connecticut
    Connecticut Mental Health Center
Jul 11, 2022

Bipolar Depression Trial in New York (Cariprazine)

Not yet recruiting
  • Bipolar Depression
  • New York, New York
    Columbia University Medical Center
Jan 23, 2023

Neurosciences Trial (Précurseur de la dopamine, antagoniste D2, PLACEBO)

Not yet recruiting
  • Neurosciences
  • Précurseur de la dopamine
  • +2 more
  • (no location specified)
Feb 1, 2023

Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse Trial in Los Angeles (Varenicline, Placebo)

Enrolling by invitation
  • Dopamine D2/3 Receptor Availability
  • +2 more
  • Los Angeles, California
    University of California Los Angeles
Mar 2, 2022

Dopamine Receptor Binding in Treatment Resistant Depression

Not yet recruiting
  • Treatment Resistant Depression
  • PET scans
  • (no location specified)
Nov 9, 2022

in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)

Withdrawn
  • in Vitro Fertilization
  • Poor Responder
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Apr 7, 2022

Health Trial in Edmonton (Dopamine, Metoclopramide, Placebos)

Recruiting
  • Health
  • Edmonton, Alberta, Canada
    Clinical Physiology Research Laboratory
Apr 6, 2022

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Parkinson Disease Trial in Seoul (A9-DPC)

Recruiting
  • Parkinson Disease
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
May 24, 2023

Diabetic Macular Edema, Diabetic Retinopathy Trial in Querétaro City, Queretaro (DME lactose pill, DME levosulpiride, DR lactose

Recruiting
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • DME lactose pill
  • +7 more
  • Querétaro City, Queretaro, Mexico
  • +1 more
Oct 31, 2022

Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,

Recruiting
  • Idiopathic Parkinson's Disease
  • PD patients H&Y=1.5-2 Medications ON
  • +4 more
  • Pozzilli, Isernia, Italy
    IRCSS Neuromed Hospital
May 18, 2022

D3 Dopamine Receptor, Cocaine-dependent, Healthy Volunteer Trial in Philadelphia ([18F]FTP PET/CT)

Active, not recruiting
  • D3 Dopamine Receptor
  • +2 more
  • [18F]FTP PET/CT
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 5, 2022

Alcohol Use Disorder Trial in Toronto ([11C]-(+)-PHNO PET scan, Alcohol Self-Administration, Craving Task)

Completed
  • Alcohol Use Disorder
  • [11C]-(+)-PHNO PET scan
  • +4 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Oct 27, 2020

Problem Gambling Among Young First-episode Psychosis

Recruiting
  • Gambling Disorder
  • Psychotic Disorders
  • Dopamine partial agonists
  • +5 more
  • Montreal, Quebec, Canada
  • +1 more
Jan 16, 2023

Schizophrenia Trial in Rockville (Lu AF35700)

Completed
Has Results
  • Schizophrenia
  • Lu AF35700
  • Rockville, Maryland
    US802
May 11, 2020

Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread Trial in Zürich (Low dose naltrexone, Placebo, Bromocriptine Mesylate

Recruiting
  • Fibromyalgia
  • +2 more
  • Low dose naltrexone
  • +3 more
  • Zürich, Switzerland
    Balgrist Campus
Feb 20, 2022

Health Volunteers, Huntington Disease Trial in Leipzig (pridopidine (90 mg))

Completed
Has Results
  • Health Volunteers, Huntington Disease
  • pridopidine (90 mg)
  • Leipzig, Germany
    Teva Investigational Site 32648
Nov 18, 2021

Plexin D1 as a Potential Biomarker inPM/DM

Not yet recruiting
  • Polymyositis
  • Dermatomyositis
  • plexinD1
  • (no location specified)
Nov 25, 2022

Advanced Parkinson's Disease Trial in Orange, New York, Toronto (MSK-DA01, MSK-DA01 Cell Delivery Device)

Active, not recruiting
  • Advanced Parkinson's Disease
  • MSK-DA01
  • MSK-DA01 Cell Delivery Device
  • Orange, California
  • +2 more
May 31, 2022

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (risperidone)

Unknown status
  • Schizophrenia
  • +2 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Feb 6, 2020

Multiple Myeloma Trial (Bone marow biopsy and aspiration, biochemical and heamatological tests)

Not yet recruiting
  • Multiple Myeloma
  • Bone marow biopsy and aspiration
  • biochemical and heamatological tests
  • (no location specified)
Aug 9, 2023

D1 vs D2 Lymphadenectomy in Gastric Cancer

Completed
  • Gastric Cancer
  • Lymphadenectomy type
  • (no location specified)
Feb 22, 2022

Functional Relevance of Dopamine Receptors in Healthy Controls

Recruiting
  • Schizoaffective Disorder
  • Schizophrenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Depression, Cognitive Impairment, Gait Impairment Trial in New York (Carbidopa/levodopa, Placebo)

    Suspended
    • Depression
    • +2 more
    • New York, New York
      New York State Psychiatric Institute
    Jan 26, 2022

    Narcolepsy With Cataplexy, Healthy Controls Trial in Toronto (Xyrem)

    Completed
    Has Results
    • Narcolepsy With Cataplexy
    • Healthy Controls
    • Toronto, Ontario, Canada
      Centre for Addiction and Mental Health (CAMH)
    Feb 26, 2021